| answer text |
<p>The European and Developing Countries Clinical Trials Partnership (EDCTP) provides
an effective coordination mechanism for clinical research. Member States provide funding
which is matched by the European Commission, and funding is also provided from third
parties (e.g. philanthropic foundations and the private sector). .</p><p> </p><p>
</p><p> </p><p>EDCTP has played an important role in research into a new tuberculosis
(TB) vaccine, by increasing the amount of TB vaccine trial activity in countries with
a high burden of TB. This includes capacity building and developing sustainable infrastructures
which will facilitate TB vaccine trials in the future, as new products emerge. EDTCP
has also helped to improve paediatric formulations of antiretroviral treatment (ART).
The findings from EDCTP-funded research were used by WHO to develop treatment guidelines
for children. This resulted in the first fixed-dose combination antiretroviral drug
being made available for a large number of HIV-infected children.</p><p> </p>
|
|
